Immunofluorescence also indicated that the expression levels of NLRP3 and caspase-1 were inhibited by gardenoside in the NAFLD cell model, but reversed by CTCF overexpression (Figures 6G–I). The gene discussed is CTCF; the disease is metabolic dysfunction-associated steatotic liver disease.